These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7862934)

  • 1. Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.
    Neisewander JL; Castañeda E; Davis DA
    Psychopharmacology (Berl); 1994 Sep; 116(1):79-84. PubMed ID: 7862934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.
    Neisewander JL; Lucki I; McGonigle P
    Brain Res; 1991 Aug; 558(1):27-35. PubMed ID: 1933381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute reserpine administration elicits long-term spontaneous oral dyskinesia.
    Sussman AN; Tran-Nguyen LT; Neisewander JL
    Eur J Pharmacol; 1997 Oct; 337(2-3):157-60. PubMed ID: 9430409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age on a new animal model of tardive dyskinesia.
    Bergamo M; Abílio VC; Queiroz CM; Barbosa-Júnior HN; Abdanur LR; Frussa-Filho R
    Neurobiol Aging; 1997; 18(6):623-9. PubMed ID: 9461060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.
    Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB
    Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice.
    Silva RH; Abílio VC; Torres-Leite D; Bergamo M; Chinen CC; Claro FT; Carvalho Rde C; Frussa-Filho R
    Behav Brain Res; 2002 May; 132(2):171-7. PubMed ID: 11997147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
    Naidu PS; Singh A; Kulkarni SK
    Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of MK-801 on reserpine-treated mice.
    Dutra RC; Andreazza AP; Andreatini R; Tufik S; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):487-95. PubMed ID: 11999899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.
    Sanghavi CR; Barhate SA; Mahajan MS; Mohan M; Kasture SB
    Nat Prod Res; 2011 Apr; 25(7):704-15. PubMed ID: 20628966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats.
    Burger ME; Fachineto R; Alves A; Callegari L; Rocha JB
    Brain Res; 2005 Jan; 1031(2):202-10. PubMed ID: 15649445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats.
    Calvente PR; Araujo CC; Bergamo M; Abilio VC; D'Almeida V; Ribeiro Rde A; Frussa FR
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):401-5. PubMed ID: 11822352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
    Naidu PS; Singh A; Kulkarni SK
    Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of buspirone on an animal model of tardive dyskinesia.
    Queiroz CM; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Nov; 23(8):1405-18. PubMed ID: 10631766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of monosialoganglioside on a new model of tardive dyskinesia.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Oct; 21(7):1169-79. PubMed ID: 9421829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia.
    Neisewander JL; Castañeda E; Davis DA; Elson HJ; Sussman AN
    Eur J Pharmacol; 1996 Jun; 305(1-3):13-21. PubMed ID: 8813526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.
    Rosengarten H; Bartoszyk GD; Quartermain D; Lin Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):273-9. PubMed ID: 16229932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.